Based on recent data, Serina Therapeutics, Inc. (SER) shows an Average True Range (ATR) of 0.27 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 1.27M, indicating liquidity. These fundamental metrics provide insight into SER's underlying financial health and market activity.
| ATR | 0.27 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 1.27M |
| Avg Vol (10 Days) | 63.71K |
Serina Therapeutics, Inc. (SER) technical indicators as of March 3, 2026: the SMA 20 is -16.18%, SMA 50 at -25.13%, and SMA 200 at -59.25%. The RSI 14 value is 40.43, suggesting its current momentum. These technical analysis signals help assess SER's price trends and potential future movements.
| SMA 20 | -16.18% |
| SMA 50 | -25.13% |
| SMA 200 | -59.25% |
| RSI 14 | 40.43 |
Serina Therapeutics, Inc. (SER) stock performance overview as of March 3, 2026: The 52-week high is $7.92 (currently -77.15% below), and the 52-week low is $1.53 (currently 17.98% above). Over the past year, SER's performance is -40.33%, compared to the S&P 500's 12.64% change.
| 52-Week High | 7.92 |
| 52-Week High Chg | -77.15% |
| 52-Week Low | 1.53 |
| 52-Week Low Chg | +17.98% |
| S&P 500 52-Week Chg | 12.64% |
According to market data, Serina Therapeutics, Inc. (SER) stock's recent performance metrics show that over the last month, SER is -2.38%, with a Year-to-Date (YTD) performance of 50.03%. Over the past year, the stock has seen a -40.33% change. These figures summarize SER's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 1.86 | 3.45 | 4.26 | 5.83 | 7.92 | 4.08 |
| Low | 1.53 | 1.53 | 1.53 | 1.53 | 1.53 | 1.53 |
| Performance | +16.19% | -2.38% | -40.31% | -46.36% | -40.33% | +50.03% |
According to current financial data, SER stock's P/E (TTM) ratio is -0.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for SER, including P/S (162.25), P/B (10.25), and P/FCF (-1.14), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | SER | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -0.97 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 162.25 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 10.25 | 4.46 | 7.56 | 4.85 |
| P/FCF (TTM) | -1.14 | -8.36 | -225.34 | 33.82 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep